Patents, Lipitor | featured news

Pfizer Is Said to Pursue Nonprescription Lipitor

Pfizer hopes to have an over-the-counter version of the world’s best-selling drug after it loses patent protection.

 

Subscribe to this RSS topic: Syndicate content